Definium Therapeutics DFTX
NASDAQ DFTX
$38.41 +2.24 (+6.19%)
At close: Sep 28, 2026 · 4:00 PM EDT

Definium Therapeutics (DFTX) Long-Term Investments (2025)

Updated

Definium Therapeutics' Long-Term Investments was $54.9 million in Q2 2025, up 65.9% from the prior quarter.

Analysis

Definium Therapeutics (DFTX) Long-Term Investments (2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Johnson & Johnson 653.54 Bn 572.07 Bn 17.26 Bn -
2 AbbVie 467.01 Bn 440.17 Bn 12.70 Bn 266.00 Mn
3 Merck 367.16 Bn 321.59 Bn 12.21 Bn 1.22 Bn
4 Novartis Ag 277.56 Bn 233.43 Bn 11.24 Bn 69.00 Mn
5 Astrazeneca 258.23 Bn 231.79 Bn 12.86 Bn 2.62 Bn
6 Amgen 224.14 Bn 179.54 Bn 7.24 Bn -
7 Gilead Sciences 187.30 Bn 161.42 Bn 6.22 Bn -
8 Pfizer 163.47 Bn 110.41 Bn 10.94 Bn 1.56 Bn
9 Vertex Pharmaceuticals 133.31 Bn 105.31 Bn 2.84 Bn 5.79 Bn
10 Definium Therapeutics 4.00 Bn 4.00 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 54.90 Mn
Mar 31, 2025 33.10 Mn
API Access

Definium Therapeutics Long-Term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-investments&ticker=DFTX&period=max&api_key=YOUR_API_KEY